Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
DeFi Development Corp. Reports First Quarter 2025 Financial Results and Provides Strategic Update on Solana Treasury Activity
-
Rhythm Pharmaceuticals Announces New Data Presentations on Patients with Acquired or Congenital Hypothalamic Obesity (N=35) Treated with Setmelanotide for up to Nine Months in French Early-access Prog
-
Domestic Metals Announces Appointment of Gordon Neal as President
-
PharmaTher Unveils KetaVault™: A First-of-Its-Kind Portal to Accelerate Ketamine Research and Commercialization
-
Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)
-
Morae Acquires Information Governance Vendor Gimmal Broadening Its Technology-Based Solutions for Law Firms and Law Departments
-
Hydreight Technologies to Present at Maxim Group’s 2025 Virtual Tech Conference & the CEM Bermuda Capital Event
-
ARMLOGI HOLDING CORP. TO HOLD FISCAL 2025 THIRD QUARTER AND NINE-MONTH RESULTS CONFERENCE CALL ON FRIDAY, MAY 16
-
GSA and GSA Foundation Announce Record Support for the Geosciences
-
PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)
-
Algorhythm Holdings to Announce its Financial Results for the First Quarter 2025
-
Daxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart Journal
-
Chapman University Releases International Housing Affordability Report Revealing None of the 95 Major Markets Affordable
-
Project EverGreen and ScottsMiracle-Gro Expand Green Spaces at Heat-stressed Phoenix Park
-
3Daughters Selects Connect Labs by Wexford - Baltimore for New Corporate Headquarters
-
Patriot Mobile Powers Jason Aldean’s Full Throttle Tour Sweepstakes
-
SailPoint to Announce Fiscal First Quarter 2026 Results on June 11, 2025
-
BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders
-
Redfin and Magnite Join Forces to Give Advertisers Priority Access to Audience Targeting Across the Homebuying Journey
-
Heartland Oncology and Hematology Oncologist Named 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO)
-
Indaptus Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a Clinical Update
-
New Episode Now Streaming on Alpha Liquid Podcast, Bittensor, Decentralizing Artificial Intelligence
-
Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
-
KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
NewAmsterdam Pharma to Present at the 2025 RBCCM Global Healthcare Conference
-
Photronics to Report Second Quarter Earnings
-
INmune Bio Inc. Announces Attendance at the 2025 RBC Capital Markets Global Healthcare Conference
-
Powerdyne International Inc. Announces A letter to the Shareholders update
-
Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing
-
Technip Energies appoints Marco Tiziano Barone as Chief Legal Officer
-
OxyCon Returns: The Flagship Web Scraping Conference Opens 2025 Registration
-
A comparative sNPWT study of 10,000+ C-sections shows PICO™ sNPWT reduces complications and cuts healthcare costs by $728,000 per 1,000 patients
-
Michelin | Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital
-
Absorb Recognized as a Global Leader in Learning Technology by Fosway, Talented Learning and G2 in 2025
-
WeRide Accelerates Robotaxi Mass Commercialization with 8 Autonomous 24/7 Routes in Central Guangzhou
-
Waterfall Network Augments Web3 Tools with Cascadify and The Lamb
-
Avis Budget Group Announces Intention to Offer $500 Million of Senior Notes
-
Avis Budget Group Announces Intention to Offer $500 Million of Senior Notes
-
Glass House Brands and LEEF Announce MSA for The Leaf El Paseo Dispensary and Off-Take Agreement
-
Angola Entry via Strategic Partnership with Corcel plc Investment in KON-16 Onshore Kwanza Basin
-
Arabsat selects Telesat Lightspeed Low Earth Orbit (LEO) services for its multi-orbit connectivity portfolio
-
Advanced Flower Capital Inc. Announces Financial Results for the First Quarter 2025
-
Emergent BioSolutions to Participate in Upcoming Investor Conferences
-
Introduction to UXUY Protocol
-
Pony AI Inc. Announces Voluntary Extended Lock-Ups by Founders
-
Bombardier Announces Launch of US$500 million New Issuance of Senior Notes due 2033 to retire US$500 million of its Senior Notes due 2027
-
Stallion Uranium Announces Failure to File Cease Trade Order
-
Erdene Announces Q1 2025 Results and Provides Bayan Khundii Project Update
-
Plus Therapeutics’ REYOBIQ™ Shows Clinical Benefit and Safety in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases (LM)

